Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Title Grant Type Focus Area Country Application Due Date Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)Release Date:Education Hospital All Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management GuidanceRelease Date:Partner: Japanese Dermatological AssociationQuality Improvement Inflammation & Immunology Japan Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin AmericaRelease Date:Research Rare Disease All Pediatric Endocrinology FellowshipRelease Date:Fellowship Rare Disease USA Growth Hormone Research- United StatesRelease Date:Research Rare Disease USA Treatment of acute SARS-CoV-2 infection and management of post-COVID conditions in outpatient settings (European countries)Release Date:Education Hospital All Topical Hemostasis in Hospital Outpatient and Ambulatory SurgeryRelease Date:Education Hospital USA Education for Improving Appropriate Diagnosis and Treatment for Venous ThromboembolismRelease Date:Education Internal Medicine Japan Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic EmbolismRelease Date:Quality Improvement Internal Medicine Japan Atopic Dermatitis and Alopecia AreataRelease Date:Quality Improvement Inflammation & Immunology Canada Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care ProfessionalsRelease Date:Education Inflammation & Immunology USA Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada, EMD SeronoQuality Improvement Oncology Canada